Trichorhinophalangeal Syndrome Type 2

Watchlist
Retrieved
2021-01-23
Source
Trials
Drugs

A very rare, genetic, multiple congenital anomaly disorder characterized by bone abnormalities, distinctive facial features, multiple exostoses, and intellectual disability.